About – Dr. Bharat Bhosale
Dr Bharatsinha B. Bhosale is a qualified and skilled Medical Oncologist with more than 19 years of experience in Clinical Oncology and Molecular Oncology. Dr Bharat Bhosale is a research-oriented, Academic Physician and consultant Medical Oncologist, and leading one of the largest day care cancer center chains in India. Graduated from the most prestigious Tata Memorial Hospital, Mumbai and B.J. Medical College (Pune). He is currently practicing at SL Raheja Fortis Hospital in Mahim. Dr. Bhosale also works as a consultant at the Bombay Hospital Institute of Medical Science and has acquired vast experience of 9+ years as a specialist doctor in Head, Neck, Breast, and Gynaecological Cancers.
Specialization
Dr. Bharat Bhosale has gained experience in various medical specialty interventions. He has earned a stellar reputation as a trusted healthcare professional, providing comprehensive and personalized treatment to patients facing cancer diagnoses including –
- Breast cancer
- Gynecological cancer
- Head and Neck cancer
- Leukaemia and Lymphoma
- Thoracic and lung cancer
- Gastrointestinal cancers
- Pediatric Solid Tumors
- Molecular and Transitional Research
He has a primary specialty in therapy treatments too including
- Immunotherapy
- Targeted Therapy
With over a decade of experience in oncology practice, Dr. Bharat Bhosale has amassed a wealth of expertise across various cancer types and treatment modalities. Dr. Bhosale approaches each case with meticulous attention to detail, employing a multidisciplinary approach to develop tailored treatment plans that prioritize the unique needs and preferences of cancer patients.
Education
- MBBS from Maharashtra University of Health Sciences, Nashik in 2002
- MD – General Medicine from Dr. Baba Saheb Ambedkar Marathwada University in 2008
- DM – Medical Oncology from Homi Bhabha National Institute in 2012.
- ECMO – European Certified Medical Oncology in 2012
- PDCR – Professional Diploma in Clinical Research in 2013
Career
Dr. Bharat Bhosale is a certified doctor who primarily practices in Mumbai as a consultant in various hospitals from Bombay Hospital Institute of Medical Science, Jaslok and Fortis Raheja, Mumbai, Sunrise Oncology Center in Malad West, Mumbai, and Sunrise Oncology Center in Margao, South Goa. Dr. Bhosale has gained experience in the areas of Immunotherapy and Targeted Therapy and he mostly focuses on major illnesses such as Thoracic Cancer, Lung Cancer, Lymphoma & Leukemia. He also actively participates in various Cancer Awareness Programs organized in schools and colleges around Mumbai.
Compassionate Care
Dr. Bharat Bhosale places great emphasis on establishing strong doctor-patient relationships built on trust, respect, and open communication. He understands the emotional and psychological toll that a cancer diagnosis can have on individuals and their families, and he strives to provide unwavering support and guidance throughout every step of the treatment journey. He takes the time to listen to his patient’s concerns by addressing their questions and fears, ensuring they feel empowered and informed throughout the process.
Innovative Treatments and Research
Dr. Bharat Bhosale remains at the forefront of oncology advancements, continuously seeking out innovative treatments and staying abreast of the latest developments in cancer research. He is committed to offering his patients access to cutting-edge therapies, including chemotherapy, radiation therapy, immunotherapy, targeted therapy, and precision medicine. He actively participates in clinical trials and research initiatives aimed at advancing cancer treatment modalities and improving patient outcomes.
Memberships
Dr. Bharat Bhosale is a medical member of various fellowship programs and medical associations including –
- Indian Cooperative Oncology Network
- Mumbai Hematology Group
- American Society Of Clinical Oncology
- ESMO (European Society of Medical Oncology) Preceptorship on Lung Cancer, Singapore, 2014.
- ESMO (European Society of Medical Oncology) Preceptorship on Prostate Cancer, Prague, 2015.
- ESMO (European Society of Medical Oncology) Translational research Fellowship, Vienna, 2015.
- Certificate of Advanced Studies in Lung Cancer University Hospital of Zurich, May 2022.
- Advanced Certification in Molecular Oncology, Sidney Kimmel Cancer Center – Jefferson Health Thomas Jefferson University, 2023.
- Section Editor Immunotherapy for Indian Journal of Medical and Pediatric Oncology.
- Executive Committee Member Indian Society of Medical and Pediatric Oncology.
- Member of ethics committee Tata Memorial Hospital, Mumbai
- Current affiliations:
- Senior consultant Oncologist: Bombay Hospital Medical and Research Institute, Marine Lines, Mumbai.
- Visiting Consultant Oncologist –
Jaslok Hospital Medical & Research Institute, Pedder road, Mumbai • SL Raheja Fortis group of Hospital, Mahim, Mumbai.
Sir H. N. Reliance Foundation Hospital and Research Centre, Girgaon, Mumbai.
Holy Spirit Hospital, Mahakali Caves Road, Andheri, Mumbai
- Director Chemotherapy Day Care unit Andheri west , Mumbai.
2. Past affiliations:
- Consultant Medical Oncologist, Department of Medical Oncology, Tata Memorial Hospital, Parel, Mumbai (June 2012 to Nov 2013)
- Executive Committee Member ISMPO ( Indian society of Medical and Pediatric Oncology)
- Section Editor Immunotherapy IJMPO ( Indian Journal Of Medical and Pediatric oncology)
- Member of Ethics Committee Tata Memorial Hospital
3. Medical registration number: 2004/02/0746
- Professional experience:
1 – Jan 2003-Dec 2003: One-year rotatory internship at Sassoon General Hospital, Pune with 3 months posting in rural training centre, Shirur, Maharashtra.
2 – Feb 2004-June 2004: Assistant lecturer in department of Anatomy at Rangoonwala Dental College, Pune
3 – June 2005-July 2008: Registrar in internal medicine at Govt Medical College and hospital, Aurangabad
4 – Aug 2008-july 2008: Lecturer in the department of Medicine, Govt medical college and hospital, Aurangabad
5 – Aug 2009-July2012: Senior registrar, DM medical oncology in Tata Memorial Hospital, Mumbai with rotatory postings in the following fields:
- Leukemias and lymphomas: 1year
- Bone Marrow Transplantation: 6 months
- Adult solid tumors:1 year
- Administration of chemotherapy
- Management of central venous catheters
- Participation in decision-making in various Disease Management Groups(DMG)
- Paediatric Oncology (Hematolymphoid and solid tumors): 6 months o Molecular and cytogenetics lab:1 month
- Hematology lab:1 month
- Pain and Palliative care: 15 days
- Radiation Oncology: 1 month
- Gastroenterology oncology: 45 days
Awards
Dr. Bharat Bhosale has won several awards and recognitions over a period of time while training and practicing
- 1st Prize for designing trial “Adjuvant chemotherapy in node-positive hormone receptor-positive breast cancer”. ICON Nagpur, 2011.
- 1st Prize in Medical Oncology Quiz. COPE Chennai, 2012.
- Section Editor for the Indian Journal of medical and pediatric oncology.
- Invited as Faculty for UAE Cancer Congress 2013 & 2014.
- Organizational secretory, Best of ASCO 2019, National Oncology Meeting at J W Marriott, Mumbai
- Indian Achievers Award in 2022
Clinical trial and research experience:
Abstracts published in various international and national journals:
1 – Bharatsinha Bhosale, Pankaj Dwivedi, Vijay Patil, M Vamshi Krishna, Ravi T, Nitin Inamdar, Ruprekha Hegade, Tushar Vora, Girish Chinnaswamy, P kurkure, S D Ba navali. Is vitamin D deficiency associated with advanced cancers in children? .(Accepted: Pediatric Blood and Cancer,DOI 10.1002/pbc)
2 – Pankaj Dwivedi, Bharat Bhosale, Ravi T, Saurabh Radhakrishnan, Tushar Vora, Girish Chinnaswamy, Brijesh Arora, Shripad Banavali.Single dose/ single vial (1.5mg) rasburicase in the management of pediatric patients with hyperurecimia and/or tumor lysis syndrome. Experience from Tata Memorial Centre.(Accepted as an abstract in Pediatric Blood and Cancer, Oct 2012)
3 – V. Naronha, K Prabhash, B Bhosale, A. Joshi. AOS28 High pathological response rate with docetaxel plus cisplatin plus fluorouracil induction regimen in oesophageal cancer: Initial experience. European Journal of Cancer; Volume 48, Supplement 4, Page S13, April 2012
4 – B. Bhosale, Ravi T, N Kumar, S Radhakrishnan, B Bagal, A Joshi, S Kanan, H Menon, M Sengar, R Nair, N Khattry. Long term results of autologous transplants for lymphomas from Tata Memorial Center.Indian J Hematol Blood Transfus 2011; 27(4): 185- 289.(Abstract: P127)
5 – R. Thippeswamy, L. Mathew, B. Bhosale, N. Kumar, S. Kannan, A. Joshi, V. Ran garajan, N. Khattry. LACE: A conditioning regimen for patients with lymphoma undergoing autologous transplant. J Clin Oncol 29: 2011 (suppl; abstr 6591).
6 – S.Mittal, Ravi T, DK Rajamanickam, A Gokarn, B Bhosale, S Kannan, B Bagal, J Gawande, R Nair, N Khattry.Incidence, Risk factors and outcome of Engraftment Fever Post Autologus Transplant for Lymphomas. Indian J Hematol Blood Transfus 2011; 27(4):185-289.(Abstract: P133)
7 – Navin Khattry, Reetu Jain, Ravi Tippeswamy, Adwaita Gore, Bharat Bhosale, Sad hana Kannan, Amit Joshi, Reena Nair, Tapan Saikia- on behalf of Indian Society of Oncology Group (ISOG). Comparison of Toxicity and Outcomes of BCNU-contain-ing Conditioning Regimens vs LACE in Lymphoma Transplants: A Retrospective Multicenter Analysis. Blood,2011; Vol.118 ,No.21.
8 – V. Ostwal, N. Ghadyalpatil, K. Prabhash, H. Menon, R. Nair, M. Sengar, V. Noronha, S. Biswas, B. Bhosale, S. Banavali. Reactivation of latent viral hepatitis infection in patients of chronic myeloid leukemia treated with imatinib mesylate: Experience from a tertiary cancer center in India. J Clin Oncol 28:15s, 2010 (suppl; abstr 6593).
Publications:
9 – Patil VM, Noronha V, Joshi A, Muddu V, Bhosale B, Bakshi G, Prabhash K. Pallia- tive chemotherapy in carcinoma penis: Does platinum and taxane combination holds a promise?. Urology annals. 2014 Jan;6(1):18.
10 – Patil VM, Noronha V, Muddu VK, Gulia S, Bhosale B, Arya S, Juvekar S, Chatturve-di P, Chaukar DA, Pai P, D’cruz A. Induction chemotherapy in technically unre- sectable locally advanced oral cavity cancers: does it make a difference?. Indian jour-nal of cancer. 2013 Jan 1;50(1):1.
11 – Krishna VM, Noronha V, Prabhash K, Joshi A, Patil V, Bhosale B, Ravi T, Menon H,Gupta S, Banavali SD, Bakshi G. Sunitinib in metastatic renal cell carcinoma:Asin-gle-center experience. Indian journal of cancer. 2013 Jul 1;50(3):268.
12 – Noronha V, Joshi A, Patil VM, Bhosale B, Muddu VK, Banavali S, Kelkar R, Prab- hash K. Pattern of infection, therapy, outcome and risk stratification of patients with febrile neutropenia in a tertiary care oncology hospital in India. Indian journal of can cer. 2014 Oct 1;51(4):470.
13 – Pandey A, Bhosale B, Pandita V, Singh A, Ghosh J, Ghosh J, Bajpai J. Carboplatin hypersensitivity in relapsed ovarian carcinoma: A therapeutic challenge. Indian journal of medical and pediatric oncology: official journal of Indian Society of Medical & Paediatric Oncology. 2014 Jan;35(1):17.
14 – Patil V, Noronha V, Joshi A, Muddu Krishna V, Juvekar S, Pantvaidya G, ChaturvediP, Chaukar D, Arya S, Patil A, Bhosale B. Is there a limitation of RECIST criteria in prediction of pathological response, in head and neck cancers, to post induction chemotherapy?. ISRN oncology. 2013 Sep 11;2013.
15 – Banavali SD, Patil NR, Nirabhawane VS, Bhosale BB, Desai SB. Can combination Metronomic therapy overcome chemoresistance in cholangiocarcinoma? A literature review. Indian journal of cancer. 2013 Apr 1;50(2):149.
16 – Noronha V, Prabhash K, Bhosale B, Joshi A. AOS28 High pathological response rate with docetaxel plus cisplatin plus fluorouracil induction regimen in oesophageal can cer: Initial experience. European Journal of Cancer. 2012 Apr 1;48:S13.
17 – Thippeswamy R, Mathew L, Bhosale B, Kumar N, Kannan S, Joshi A, Rangarajan V, Khattry N. LACE: A conditioning regimen for patients with lymphoma undergoing autologous transplant. Journal of Clinical Oncology. 2011 May 20;29(15_suppl): 6591-.
18 – Katna R, Kalyani N, Agrawal S, Bhosale B.: Impact of co-morbidities on perforative outcomes for carcinoma of oral cavity. Accepted for publication in Annals Journal & Bulletin Journal.
19 – Gautam Goyal ,a Singh < M Avaronnan, N Raut, V Talreja, A Chandrashekharan, Bharat Bhosale.Treatment pattern and outcomes of leptomeningeal carcinomatosis in India- a retrospective study.the lancet.con vol 2023
20 – P M Majumdar, M Morekar, S khadilkar, Bharat Bhosale. June 2022 Oman Journal of Ophrthalmology. A case of NHL diagnosed after 35 months of initial presentation as recurrent vitritis.
21 – Katna R, Kalyani N, Agarwal S, Singh S, Deshpande A, Bhosale B; Mumbai Oncology Group – Head and Neck. Impact of comorbidities on perioperative outcomes for carcinoma of oral cavity. Ann R Coll Surg Engl. 2020 Mar;102(3):232-235. doi: 10.1308/rcsann.2019.0155. Epub 2019 Dec 16. PMID: 31841025; PMCID: PMC7027403.
22 – Katna R, Kalyani N, Singh S, Bhosale B; Mumbai Oncology Group – Head and Neck. Compartmental Clearance of Infratemporal Fossa for T4b Carcinoma of Buccal Mucosa/Alveolus: Clinical Outcomes. Indian J Surg Oncol. 2020 Jun;11(2):316-320. doi: 10.1007/s13193-020-01057-y. Epub 2020 Mar 30. PMID: 32523282; PMCID: PMC7260297.
23 – Katna R, Bhosale B, Sharma R, Singh S, Deshpande A, Kalyani N. Oncological outcomes in patients undergoing major glossectomy for advanced carcinoma of the oral tongue. Ann R Coll Surg Engl. 2020 Sep;102(7):514-518. doi: 10.1308/rcsann.2020.0100. Epub 2020 May 21. PMID: 32436723; PMCID: PMC7450443.
24 – Katna R, Kalyani N, Deshpande A; Mumbai Oncology Group – Head and Neck. Free thyroid transfer to anterolateral thigh for prevention of radiation induced hypothyroidism: An initial experience. Am J Otolaryngol. 2019 Mar-Apr;40(2):160- 163. doi: 10.1016/j.amjoto.2018.12.013. Epub 2018 Dec 21. PMID: 30594401.
25 – Katna R, Singh S, Bhosale B, Deshpande A, Kalyani N; Mumbai Oncology Group – Head and Neck. Microvascular reconstruction for head and neck cancers in high risk population: clinical outcomes and complications. Ann R Coll Surg Engl. 2021 Apr;103(4):278-281. doi: 10.1308/rcsann.2020.7078. Epub 2021 Mar 8. PMID: 33682450.
26 – Katna R, Girkar F, Tarafdar D, Bhosale B, Singh S, Agarwal S, Deshpande A, Kalyani N; Mumbai Oncology Group – Head and Neck. Pedicled Flap vs. Free Flap Reconstruction in Head and Neck Cancers: Clinical Outcome Analysis from a Single Surgical Team. Indian J Surg Oncol. 2021 Sep;12(3):472-476. doi: 10.1007/s13193- 021-01353-1. Epub 2021 May 17. PMID: 34658573; PMCID: PMC8490574.
27 – Katna R, Naik G, Girkar F, Deshpande A, Chalke S, Bhosale B, Kalyani N. Clinical outcomes for microvascular reconstruction in oral cancers: experience from a single surgical centre. Ann R Coll Surg Engl. 2022 Feb 17. doi: 10.1308/rcsann.2021.0295. Epub ahead of print. PMID: 35175143.
28 – Katna R, Naik G, Girkar F, Deshpande A, Chalke S, Bhosale B, Kalyani N. Clinical outcomes for microvascular reconstruction in oral cancers: experience from a single surgical centre. Ann R Coll Surg Engl. 2023 Mar;105(3):247-251. doi: 10.1308/rcsann.2021.0295. Epub 2022 Feb 17. PMID: 35175143; PMCID: PMC9974342.
29 – Katna R, Bhosale B, Naik G, Girkar F, Patil V, Karpe A, Kalyani N; Mumbai Oncology Group – Head, Neck. Role of Selective Neck Dissection in Clinically Single Node Positive Disease in Oral Cavity Cancers. Indian J Surg Oncol. 2023 Sep;14(3):644-650. doi: 10.1007/s13193-023-01730-y. Epub 2023 Mar 7. PMID: 37900649; PMCID: PMC10611670.
30 – R. Katna, A. Maini, P. Paatni, B. Bhosale, A. Karpe, S. Chalke, N. Kalyani, On behalf of Mumbai Oncology Group – Head and Neck, Re-classifying cT4b buccal mucosa / Gingivo-buccal complex cancers: Do we need to change?, British Journal of Oral & Maxillofacial Surgery (2024), doi:https://doi.org/10.1016/j.bjoms.2024.08.004
31 – Nikhil Kalyani, Bharat Bhosale, Shambhavi Singh, Debayan Tarafdar, Rakesh Katna. Distant Metastasis in Carcinoma Oral Cavity: Incidence and Prognostic Factors. Ind J Med Paediatr Oncol 2021;42:46–50.
32 – Bhosale Bharat; Katna, Rakesh; Kalyani Nikhil. Adaptive approach toward the management of head-and-neck cancers during the COVID-19 crisis. Cancer Research, Statistics, and Treatment 3(2):p 324-325, Apr–Jun 2020. | DOI: 10.4103/CRST.CRST_178_20
33 – Katna Rakesh; Kalyani, Nikhil; Bhosale Bharat. Changing treatment paradigms in advanced sinonasal neuroendocrine cancers. Cancer Research, Statistics, and Treatment 3(3):p 651-652, Jul–Sep 2020. | DOI: 10.4103/CRST.CRST_229_20
34 – Fathima Nusrath, Verma Krithika; Subramanyam Paridhy V; Mukherjee Nilesh, Bharat Bhosale et al. Molecular insights from comprehensive genomic profiling data in advanced metastatic colorectal cancer in South Asian population: A retrospective observational study.CRST: 7(2):p 193-205, Apr–Jun 2024. | DOI: 10.4103/crst.crst_30_24
35 – Kumar Prabhash et al. Treatment of advanced non-small-cell lung cancer.CRST;Cancer Research, Statistics, and Treatment, 2021, № 2, p. 279-314
36 – Ganesh Divekar, Bharat Bhosale , P Kulkarni.History of Paclitaxel and Oral Paclitaxel – Clinical Data and Future. Indian Journal of Medical and Paediatric Oncology 41(2):260
37 – P. Parikh, B. Bhosale, N Likeshwar .Mediclaim insurance challenges and solutions – Doctors supporting patients: A Medic LAWgic initiative. Indian Journal Of Medical Sciences . 71(1); 22-27doi: 10.25259/IJMS_13_2019
7. ICH-GCP training: Yes
One of the leading pioneer Medical Oncology doctors with more than 15 years of experience in this field. He says “Cancer is not death” and with advancements in treatment modalities, there are patients who survive to live longer. He also believes that there are social stigmas associated with cancer in society and it needs to be cleared through proper cancer awareness programs and doctor consultation. Dr. Bharat spends a lot of his time contributing to society with efficient treatment access for even low-income cancer patients.
Email address: bharatsinghbhosale@gmail.com
E-connect:
Twitter: https://twitter.com/Bhosale26Bharat
Instagram: https://www.instagram.com/bharat9601/
LinkedIn: https://www.linkedin.com/in/bharat-bhosale-831a7248/
YouTube: https://www.youtube.com/@BharatBhosale